WebJul 17, 2024 · Evoke Pharma (NASDAQ:EVOK) has a market capitalization of $6.75 million and generates $2.51 million in revenue each year. The … WebStock analysis for Evoke Pharma Inc (EVOK:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Evoke Pharma Stock Price Today (NASDAQ: EVOK) Quote, Market …
WebApr 10, 2024 · Estimated DCF Value of one EVOK stock is 17.97 USD. Compared to the current market price of 2.02 USD, the stock is Undervalued by 89%. The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the … WebEVOK Profile. Company Profile. Evoke Pharma Inc. 420 Stevens Avenue. Suite 370. ... Transaction Type Share Price Shares Value; Dec 14, 2024 Sale: David A. Gonyer … fantasy football strength of schedule 2018
EVOK vs. Dogecoin - cryptocurrencieschannel.com
WebGlobeNewswire -8.03%. Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with ... Web19 hours ago · About Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a … WebStock analysis for Evoke Pharma Inc (EVOK:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. cornwall council business plan 2022 to 2026